Tg Therapeutics (TGTX) Capital Expenditures Growth (1y) (2013 - 2026)
Tg Therapeutics (TGTX) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Tg Therapeutics |
7.71 Bn |
7.06 Bn |
171.41 Mn |
104.00% |
| Date | Value |
|---|
| Mar 31, 2026 |
104.00% |
| Dec 31, 2025 |
219.05% |
| Sep 30, 2025 |
233.33% |
| Dec 31, 2022 |
-96.25% |
| Sep 30, 2022 |
-94.94% |
| Mar 31, 2022 |
-89.55% |
| Dec 31, 2021 |
-48.39% |
| Sep 30, 2021 |
-11.24% |
| Jun 30, 2021 |
288.89% |
| Mar 31, 2021 |
-1.47% |
| Dec 31, 2020 |
355.88% |
| Sep 30, 2020 |
36.92% |
| Jun 30, 2020 |
150.00% |
| Mar 31, 2020 |
385.71% |
| Dec 31, 2019 |
466.67% |
| Sep 30, 2019 |
150.00% |
| Jun 30, 2019 |
-47.06% |
| Mar 31, 2019 |
-41.67% |
| Jun 30, 2018 |
1,600.00% |
| Jun 30, 2017 |
-92.80% |
